Company Overview and News
Started in 1870 as a small branch of its UK parent, Swire Pacific is a major player in property, beverages, aviation, marine services and trading and industries
90 U.S. Exchange stocks displayed 10%+ forward yield, $3-$33 prices, and $100M+ market caps as of November 28. Yields above 13.1% narrowed the list to 30 for comparison.
Chinese consumers are increasingly opting for healthier drink options, including premium packaged waters and energy drinks, forgoing classic soft drinks such as Coca-Cola and Fanta, according to Patrick Healy, managing director of Swire Beverages.
Oct 17 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1000 GMT on Tuesday:
HONG KONG (Reuters) - China Foods Ltd (0506.HK) said it would sell its wine and other non-beverage businesses to a unit of its state-owned parent COFCO Corp in a deal valued at HK$5.07 billion ($649 million) as it aims to focus on its beverage business.
Chicago, IL – November 28, 2016 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include NIKE, Inc. (NYSE:(NKE - Free Report) –Free Report),Boeing Company (NYSE:(BA - Free Report) –Free Report),Textron Inc. (NYSE:(TXT - Free Report) –Free Report),Coca-Cola Company (NYSE:(KO - Free Report) –Free Report) and IBM Corporation (NYSE:(IBM - Free Report) – Free Report).
The Dow enjoyed another week of substantial gains following optimism about Donald Trump’s policy proposals. Meanwhile, economic data released over most of the week was encouraging. Oil prices moved higher following speculation that OPEC’s member countries and Russia were close to reaching an agreement on curtailing crude output. Additionally, prospects of the Fed hiking rates in December continued to improve.
The Coca-Cola Company (KO - Free Report) entered into an agreement to divest its bottling assets in China for 5.87 billion yuan ($852 million), as part of its refranchising strategy to focus more on its core strengths of building great brands and leading a strong, global franchise system. The agreement has been signed between Coca-Cola and its three main bottling groups in China: Coca-Cola Bottling Investments Group China (“BIG”), COFCO Coca-Cola Beverages Limited (a subsidiary of COFCO Corporation, “COFCO”) and Swire Beverages Holdings Limited (“Swire”).
Coca-Cola (NYSE:KO) says it reached a definitive agreement to sell its bottling assets in China for ~$1B, part of a global divestment drive in a bid to cut costs amid slowing soda sales.
HONG KONG Hong Kong conglomerate Swire Pacific Ltd (0019.HK) said on Friday it will acquire Coca-Cola bottling assets in China for 5.87 billion yuan ($852 million), betting on growing consumption in the mainland of non-alcoholic ready-to-drink beverages.
HONG KONG: Hong Kong conglomerate Swire Pacific Ltd is nearing the acquisition of Coca-Cola bottling assets in China from a unit of state-owned food giant Cofco Corp, people with knowledge of the matter said.
HONG KONG (Nov 17): Hong Kong conglomerate Swire Pacific Ltd is nearing the acquisition of Coca-Cola bottling assets in China from a unit of state-owned food giant Cofco Corp, people with knowledge of the matter said.
BRUSSELS The European Commission has pushed back its deadline for a decision on ChemChina's plan to acquire Swiss pesticides and seeds group Syngenta (SYNN.S) by 10 working days to March 29.
BEIJING China's Great Wall Asset Management is planning to seek five to eight foreign or domestic strategic investors in a pre-IPO funding round, Zhang Shixue, the company's general manager of strategic development said on Thursday.
LONDON Battered bonds and emerging market currencies enjoyed some respite on Thursday as the dollar took a breather from a post-U.S. election charge that has taken it to a 13-1/2 year high.
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...